Name: Rovalpituzumab Biosimilar - Anti-DLL3 mAb - Research Grade
SKU: PX-TA1397
Availability: InStock

Wide range of unique reagents
Free shipping in EU on Orders > €500
Fast worldwide delivery

Size	100ug, 1MG
Isotype	IgG1, kappa
Brand	ProteoGenix
Product type	Primary Antibodies
Clonality	Monoclonal Antibody
Expression system	Mammalian cells
Applications	Elisa, WB

Cancer Primary Antibodies ELISA WB Therapeutic Antibodies

Product name	Rovalpituzumab Biosimilar - Anti-DLL3 mAb - Research Grade
Source	CAS 1613313-01-1
Species	Humanized
Expression system	Mammalian cells
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Aliases /Synonyms	Rovalpituzumab,,DLL3,anti-DLL3
Reference	PX-TA1397
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

Description of Rovalpituzumab Biosimilar - Anti-DLL3 mAb - Research Grade

General information on Anti-DLL3[Homo sapiens] (Rovalpituzumab) Monoclonal Antibody

Rovalpituzumab has been investigated for the treatment of Glioblastoma, Malignant Melanoma, Other Solid Tumors, Small Cell Lung Cancer, and Medullary Thyroid Cancer.

Datasheet Download

MSDS Download

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Price and Availability

Size

Clear

GET A QUOTE NOW

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade

Description of Rovalpituzumab Biosimilar - Anti-DLL3 mAb - Research Grade

General information on Anti-DLL3[Homo sapiens] (Rovalpituzumab) Monoclonal Antibody

REVIEW YOUR PRODUCT

Contact us

Cart (0 Items)